OBREDON (NOVOTEC PHARMA LLC)
Welcome to the PulseAid listing for the OBREDON drug offered from NOVOTEC PHARMA LLC. This Opioid Agonist [EPC],Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | NOVOTEC PHARMA LLC |
NON-PROPRIETARY NAME: | Hydrocodone Bitartrate and Guaifenesin |
SUBSTANCE NAME: | HYDROCODONE BITARTRATE; GUAIFENESIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Opioid Agonist [EPC],Opioid Agonists [MoA] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-12-30 |
END MARKETING DATE: | 2018-06-30 |
OBREDON HUMAN PRESCRIPTION DRUG Details:
Item Description | OBREDON from NOVOTEC PHARMA LLC |
LABELER NAME: | NOVOTEC PHARMA LLC |
DEA SCHEDULE: | CII
|
ACTIVE STRENGTH: | 2.5; 200(mg/5mL; mg/5mL) |
START MARKETING DATE: | 2014-12-30 |
END MARKETING DATE: | 2018-06-30 |
PRODUCT ID: | 69166-523_5b21dbc4-23fe-1d3b-e053-2a91aa0adfef |
PRODUCT NDC: | 69166-523 |
APPLICATION NUMBER: | NDA205474 |
Other HYDROCODONE BITARTRATE; GUAIFENESIN Pharmaceutical Manufacturers / Labelers: